Can-Fite BioPharma (CANF) Other Non-Current Assets (2014 - 2018)

Can-Fite BioPharma (CANF) has 4 years of Other Non-Current Assets data on file, last reported at $2000.0 in Q4 2018.

• For the quarter ending Q4 2018, Other Non-Current Assets fell 60.0% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2018 stood at $2000.0 (down 60.0% YoY), and the FY2018 full-year result was $2000.0, down 60.0% from the prior year.
• Other Non-Current Assets was $2000.0 for Q4 2018 at Can-Fite BioPharma, down from $5000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $12000.0 in Q1 2014 to a low of $2000.0 in Q4 2018.
• A 4-year average of $7250.0 and a median of $7500.0 in 2016 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets tumbled 50.0% in 2017 and tumbled 60.0% in 2018, its largest moves.
• Can-Fite BioPharma's Other Non-Current Assets stood at $12000.0 in 2014, then declined by 16.67% to $10000.0 in 2016, then tumbled by 50.0% to $5000.0 in 2017, then tumbled by 60.0% to $2000.0 in 2018.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2000.0 in Q4 2018, $5000.0 in Q4 2017, and $10000.0 in Q4 2016.